TLR4 and neoplasm: Thus, we find that docetaxel increases lymphangiogenesis in tumor-bearing fat pads and this is mediated in part by VEGFC, but also by a host of other pro-lymphangiogenic cytokines likely induced by TLR4 pathway activation by taxanes as discussed earlier.